FIELD: medicine.
SUBSTANCE: invention is intended for correction of digestive system homeostasis in patients with overweight or obesity of I degree and intestinal dysbiosis. In a combination with standard therapeutic nutrition, drug-free nutritional metabolic agents based on biologically active additive are administered. Biologically active additive used is a complex biocorrector Eykozim-10 in a dose of 900 mg a day with duration of drug-free therapy course of not less than 21 days.
EFFECT: method provides higher therapeutic effect for patients with accompanying disturbed lipid metabolism.
1 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF METABOLIC DISORDERS IN PERSONS OF WORKING AGE WITH INCREASED BODY WEIGHT INDEX (BWT) | 2019 |
|
RU2711540C1 |
| METHOD FOR CORRECTION OF ORGANISM DIGESTIVE SYSTEM HOMEOSTASIS DISRUPTION | 2010 |
|
RU2448529C1 |
| METABOLIC CORRECTION METHOD IN PATIENTS WITH PROTEIN-ENERGY INSUFFICIENCY (PEI) | 2019 |
|
RU2714315C1 |
| METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
| METHOD OF CORRECTING VAGINAL DYSBIOSIS IN CASE OF METABOLIC SYNDROME | 2012 |
|
RU2484669C1 |
| METHOD FOR CORRECTION OF METABOLIC DISORDERS AND SYSTEM OF ANTIOXIDANT PROTECTION IN METABOLIC SYNDROME WITH FATTY LIVER INVOLVEMENT | 2019 |
|
RU2701159C1 |
| COMPOSITION FOR CORRECTION OF DYSLIPIDEMIA AND MAINTENANCE OF FUNCTIONAL STATE OF HUMAN BODY IN METABOLIC SYNDROME | 2018 |
|
RU2681853C1 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
| METHOD FOR TREATING AND PREVENTING ATHEROSCLEROSIS IN NON- MEDICAMENTOUS WAY | 2000 |
|
RU2191588C2 |
| METHOD FOR CORRECTING METABOLIC DISORDERS IN PERIMENOPAUSAL WOMEN | 2021 |
|
RU2767879C1 |
